HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michelle R Lofwall Selected Research

Substance-Related Disorders (Drug Abuse)

1/2020Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
1/2019Substance Use Disorder Assessment, Diagnosis, and Management for Patients Hospitalized With Severe Infections Due to Injection Drug Use.
1/2018In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs.
1/2017Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.
12/2015States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.
4/2005Characteristics of older opioid maintenance patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michelle R Lofwall Research Topics

Disease

31Opioid-Related Disorders (Opiate Addiction)
05/2022 - 03/2010
10Miosis
09/2021 - 12/2008
8Pain (Aches)
11/2019 - 10/2010
6Substance-Related Disorders (Drug Abuse)
01/2020 - 04/2005
5Respiratory Insufficiency (Respiratory Failure)
09/2021 - 12/2008
5Infections
01/2020 - 01/2013
4Cocaine-Related Disorders (Cocaine Addiction)
06/2013 - 01/2007
3Opiate Overdose
01/2019 - 04/2017
2Tobacco Use Disorder (Nicotine Dependence)
01/2020 - 06/2014
2Hallucinations (Hallucination)
01/2020 - 11/2006
2Mental Disorders (Mental Disorder)
01/2017 - 12/2012
1COVID-19
05/2022
1Ataxia (Dyssynergia)
01/2020
1Drug Overdose
01/2020
1Drug Misuse
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2020
1Weight Gain
09/2019
1Postherpetic Neuralgia
01/2018
1Epilepsy (Aura)
03/2017
1Neoplasms (Cancer)
03/2017
1Crohn Disease (Crohn's Disease)
01/2017
1Arthritis (Polyarthritis)
01/2017
1Chronic Pain
01/2017
1Tachycardia (Tachyarrhythmias)
07/2016
1Sinus Tachycardia
12/2015
1Rhinorrhea
11/2013
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2013
1Sneezing
11/2013
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2013
1Anxiety Disorders (Anxiety Disorder)
12/2012
1Mydriasis
10/2012
1Exotropia (Exophoria)
12/2008

Drug/Important Bio-Agent (IBA)

23Opioid Analgesics (Opioids)IBA
05/2022 - 04/2005
21Buprenorphine (Subutex)FDA LinkGeneric
05/2022 - 03/2010
11Pharmaceutical PreparationsIBA
09/2021 - 12/2012
8Oxycodone (Oxycontin)FDA LinkGeneric
07/2021 - 06/2012
6Analgesics (Analgesic Drugs)IBA
11/2019 - 09/2010
4Tramadol (K315)FDA LinkGeneric
11/2013 - 09/2010
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2018
3Dronabinol (THC)FDA LinkGeneric
11/2019 - 12/2015
3Naloxone (Narcan)FDA LinkGeneric
01/2019 - 01/2018
3Cocaine (Cocaine HCl)IBA
01/2018 - 01/2013
3Illicit Drugs (Recreational Drugs)IBA
01/2018 - 04/2005
2Oxymorphone (Numorphan)FDA LinkGeneric
09/2021 - 01/2016
2Gabapentin (Neurontin)FDA LinkGeneric
01/2020 - 01/2018
2mu Opioid Receptors (mu Opioid Receptor)IBA
03/2019 - 12/2015
2Narcotic Antagonists (Opioid Antagonists)IBA
01/2019 - 10/2018
2Hydromorphone (Dilaudid)FDA LinkGeneric
01/2017 - 10/2012
2Opiate AlkaloidsIBA
06/2012 - 12/2008
1Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2020
1Pregabalin (Lyrica)FDA Link
01/2020
1AticaprantIBA
01/2020
1NicotineFDA Link
01/2020
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
01/2020
1Cannabinoid Receptor AgonistsIBA
11/2019
1Methadone (Dolophine)FDA LinkGeneric
09/2019
1insulin receptor-related receptor (IRR)IBA
01/2019
1Caffeine (No Doz)FDA LinkGeneric
01/2018
1Delayed-Action PreparationsIBA
01/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2018
1Therapeutic UsesIBA
03/2017
1CannabinoidsIBA
07/2016
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
07/2016
1Aripiprazole (Abilify)FDA Link
06/2014
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
06/2013
1Methamphetamine (Desoxyn)FDA LinkGeneric
12/2012
1Naltrexone (ReVia)FDA LinkGeneric
10/2012
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2012
1Naloxone Drug Combination BuprenorphineFDA Link
08/2011
1CatecholaminesIBA
09/2010
1Heroin (Diamorphine)IBA
12/2008
1KetamineFDA LinkGeneric
11/2006

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2019 - 01/2007
2Therapeutics
01/2020 - 11/2019
2Self Administration (Administration, Self)
01/2020 - 08/2012
2Analgesia
11/2019 - 01/2017
1Injections
11/2021
1Length of Stay
01/2020
1Drug Tapering
12/2015
1Opiate Substitution Treatment
01/2013